Acquires next generation tissue-targeted C3d-Factor H fusion protein complement inhibitor from Q32 BioPhase 2 basket trial planned to evaluate ...
Chonnam National University Hospital succeeded in introducing Impella for the first time in the coun... Chonnam National ...
In a recent meta-analysis which included individual-patient data from five randomized trials, beta-blocker therapy did not ...